4:13 PM EST - : Lapolla Industries, Inc. : announced that it has contracted with Exova, a nationally accredited Canadian testing laboratory, to conduct the In-Field Quality Assurance Program for the FL-2000 (FoamLOK), Evaluation listing CCMC 13414-L. Exova was recently added to the short list of qualified In-Field Inspection Firms recognized by CCMC for the Canadian markets. Lapolla Industries, Inc. is a leading manufacturer and supplier of spray polyurethane foam for insulation and coatings targeting residential and commercial applications in the building envelope construction industries.

4:11 PM EST - : Advance Nanotech, Inc.: reported financial results this week for the three months ended September 30, 2009. The Company reported net income of $2,417,351, or $0.04 per share, compared to a loss of $382,555, or $0.01 per share, for the three months ended September 30, 2008. During the nine months ended September 30, 2009, the Company reported a net loss of $3,662,926, or $0.07 per share, compared to a net loss of $3,831,661, or $0.10 per share, for the nine months ended September 30, 2008, a decrease of 4%.

11:43 AM EST - : China Crescent Enterprises, Inc: announced it has filed its third-quarter 2009 financial results, and reported $30 million in revenue through the nine months ending September 30, 2009 and a record net income of $1.8 million compared to $517,000 in net income for the same period in 2008. The Company has forecasted profitable revenue growth in 2009 compared to 2008. The Company reported over $40 million in profitable revenue in 2008.

11:29 AM EST - : Artfest International, Inc.: announced that it has generated $896,404 in operating revenue in the third quarter ending September 30, 2009 as compared to $4,000 in operating revenue for the third quarter ending September 30, 2008, which is an increase of 22,310%. Artfest International, Inc. also reported net income of $7,397 for the third quarter ending September 30, 2009 versus a loss of $29,862 for the same period in 2008. Artfest International reported total assets of $3,421,019 for the third quarter ending September 30, 2009 as compared to $537,445 for the third quarter ended September 30, 2008, which is a 536% increase.

4:05 PM EST - : ECOtality, Inc.: announced financial results for the third quarter ended September 30, 2009. In that quarter, ECOtality recognized revenues of $1,900,002 compared to the quarter ended September 30, 2008 of $2,900,819. This reduction in revenue is largely related to the effect of the slowing economy and the focusing of resources on securing the DOE contract. Total operating expenses during those three months were $11,394,410 compared to $1,876,300 for the three months ended September 30, 2008.

4:03 PM EST - : Mexoro Minerals Ltd.: provided a corporate update on working in one of the world's richest gold belts. To date more than 60,000 tons of material has been extracted from the west side of top 15 metres of the Cieneguita gold discovery's one-kilometre-long gold discovery in Mexico. The overall grade has, so far, averaged +3 grams Au (equivalent) per ton. According to the agreement between Mexoro and its partner Minerales Rio Tinto (MRT), MRT is spending up to $9 million U.S. to fund 100% of the Cieneguita project's initial mining operation's development and construction while also funding a feasibility study for the development of a much larger operation. The Cieneguita gold discovery has proven to have excellent continuity of grades and mineralization. Gold and silver recoveries from a 5,000-ton test run of the material averaging 90% and 85% respectively.

11:38 AM EST - : Advanced Cell Technology, Inc.: announced that it filed an Investigational New Drug (IND) Application with the US Food and Drug Administration (FDA) to initiate a Phase I/II multicenter study using embryonic stem cell derived retinal cells to treat patients with Stargardt's Macular Dystrophy (SMD). Among the most common causes of untreatable blindness in the world are degenerative diseases of the retina. As many as 10 million people in the United States have photoreceptor degenerative disease. While most of these patients have Age-Related Macular Degeneration (AMD), a smaller number of patients have Stargardt's, an Orphan disease and one of the most common forms of juvenile macular blindness. The treatment for eye disease uses stem cells to re-create a type of cell in the retina that supports the photoreceptors needed for vision. These cells, called retinal pigment epithelium (RPE), are often the first to die off in SMD and AMD, which in turn leads to loss of vision.

11:37 AM EST - : Titan Energy Worldwide, Inc.: released its financial results for the third quarter of 2009. The Company reported $7.1 million in sales for the first nine months of 2009, an increase of more than 20% over the same period in 2008 and a record high for any nine month period in the Company's history. The Company also posted lower operational losses in the first nine months of 2009, a 15% decrease over the same period in the previous year.